SMTL ID : 1ta6.1

Crystal structure of thrombin in complex with compound 14b

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

hetero-oligomer

Ligands

1 x 177: 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE(Non-covalent)

177.1: 17 residues within 4Å: Chain A: H.72, Y.76, W.79, E.175, I.208, D.228, A.229, C.230, S.234, V.254, S.255, W.256, G.257, G.259, C.260, G.267, F.268 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.76, A:W.79, A:E.175, A:I.208, A:V.254, A:W.256 Hydrogen bonds: A:S.255, A:G.257, A:G.259 Water bridges: A:G.257

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tucker, T.J. et al., Design and synthesis of a series of potent and orally bioavailablenoncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position. J.Med.Chem. (1998)

Release Date

2004-06-08

Peptides

thrombin: A
Hirudin: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

thrombin

Hirudin

Related Entries With Identical Sequence